Alignment Healthcare (NASDAQ:ALHC) Insider Sells $352,403.10 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 16,506 shares of the firm’s stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $21.35, for a total transaction of $352,403.10. Following the completion of the sale, the insider owned 333,133 shares of the company’s stock, valued at approximately $7,112,389.55. The trade was a 4.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Hyong Kim also recently made the following trade(s):

• On Monday, December 29th, Hyong Kim sold 12,694 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total value of $237,885.56.
• On Thursday, October 9th, Hyong Kim sold 51,379 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.57, for a total value of $902,729.03.
• On Wednesday, October 8th, Hyong Kim sold 33,655 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.29, for a total value of $581,894.95.

Alignment Healthcare Trading Up 0.1%

Shares of ALHC stock opened at $20.95 on Friday. The business’s fifty day moving average price is $18.63 and its 200 day moving average price is $16.49. The firm has a market capitalization of $4.19 billion, a PE ratio of -174.58, a P/E/G ratio of 6.01 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $21.65.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The company had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. During the same period in the previous year, the firm earned ($0.14) EPS. The business’s revenue was up 43.5% on a year-over-year basis. As a group, sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

ALHC has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their price target on Alignment Healthcare from $20.00 to $23.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Barclays boosted their target price on Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, October 31st. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research report on Monday, November 24th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $22.00 price target on shares of Alignment Healthcare in a research note on Monday, November 3rd. Finally, Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare has an average rating of “Moderate Buy” and an average target price of $21.25.

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently bought and sold shares of the stock. Larson Financial Group LLC purchased a new stake in shares of Alignment Healthcare during the 3rd quarter worth about $33,000. GAMMA Investing LLC grew its stake in Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after buying an additional 987 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in Alignment Healthcare during the third quarter worth approximately $53,000. SBI Securities Co. Ltd. increased its position in shares of Alignment Healthcare by 4,868.9% in the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after acquiring an additional 2,970 shares in the last quarter. Finally, KBC Group NV purchased a new position in shares of Alignment Healthcare in the 2nd quarter valued at $44,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.